Answers are grounded in this paper and cite their sources.
Our findings highlight the need for clinical trials specifically focused on safety, quality of life, and treatment adherence in TNBC patients receiving neoadjuvant treatment. Close monitoring of tolerability remains crucial in this clinical setting.
No takes yet. Share an insight, caveat, or question.
Rizzo et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: